SCHEMBL8144331

SCHEMBL8144331

Cc1cc(Cl)ccc1Oc1ccc(N(C)C(=O)C2C=CC=CC2=O)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 2/20 0.36
AVPR1A P37288 2/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
SLC6A3 Q01959 3/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
LIPE Q05469 3/20 0.34
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
KCNH2 Q12809 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
POLB P06746 2/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065122 0.76 GPBAR1 (0.44) OXTRAVPR1ASLC6A2SLC6A4SLC6A3
SCHEMBL8128605 0.74 HTR2C (0.48) OXTRAVPR1ASLC6A2SLC6A4SLC6A3
SCHEMBL4062330 0.74 HTR2C (0.48) OXTRAVPR1ASLC6A2SLC6A4SLC6A3
SCHEMBL8144329 0.74 SLC6A2 (0.38) OXTRAVPR1ASLC6A2SLC6A4SLC6A3
SCHEMBL4063945 0.73 GPBAR1 (0.48) OXTRAVPR1ALIPESMN1; SMN2HTT
SCHEMBL7547286 0.73 GPBAR1 (0.45) OXTRAVPR1ASLC6A2SLC6A4SLC6A3
SCHEMBL4069077 0.66 CYP1A2 (0.41) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4066243 0.66 CYP1A2 (0.40) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4061973 0.65 KDM4E (0.60) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4058614 0.64 GRM8 (0.53) LMNAPOLBHTR2CGRM8GRM7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028945-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS Amgen Inc. (US) 2000-08-23 EP disclosed
WO-1999024404-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC. (US) 1999-05-20 WO disclosed